AURM — Natama Investment Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $3.85m
- $3.89m
Annual income statement for Natama Investment, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | ARS |
Standards: | USG | USG |
Status: | Final | Final |
Revenue | ||
Total Revenue | 0 | 0 |
Selling / General / Administrative Expenses | ||
Depreciation and Amortization | ||
Unusual Expense / Income | ||
Other Operating Expenses | ||
Total Operating Expenses | 0.037 | 0.087 |
Operating Profit | -0.037 | -0.087 |
Total Net Non Operating Interest Income / Expense | ||
Net Income Before Taxes | -0.051 | -0.1 |
Net Income After Taxes | -0.051 | -0.1 |
Net Income Before Extraordinary Items | ||
Net Income | -0.051 | -0.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -0.051 | -0.1 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -5.2 | -9.73 |
Dividends per Share |